Follow the BioArctic AB share price and the full management transaction log of the company, a publicly traded company based in Finland. Shares are listed on FI FI, under the oversight of FIN-FSA. Operating in the Health Care sector, BioArctic AB has recorded 2 insider filings. Market capitalisation: €27.7bn. The latest transaction was reported on 16 April 2025 (Purchase). Among the most active insiders: mikael smedeby. The full history is openly available.
Analysts rate BioArctic AB Hold (neutral), based on 5 analysts. Average price target: SEK 301.40.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations